Portfolio Holdings Detail for ISIN IE0007O06KL9
| Stock Name / Fund | iShares Russell 2000 Swap UCITS ETF |
| Issuer | Blackrock |
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 63
| ETF Ticker | RU2K.AS(USD) CXE |
| ETF Ticker | RU2K(USD) Euronext Amsterdam |
Holdings detail for ABT
| Stock Name | Abbott Laboratories |
| Ticker | ABT(USD) NYSE |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US0028241000 |
| LEI | HQD377W2YR662HK5JX27 |
Show aggregate ABT holdings
News associated with ABT
- Bank of America Increases Abbott Laboratories (NYSE:ABT) Price Target to $150.00
- Abbott Laboratories (NYSE:ABT – Get Free Report) had its target price upped by equities research analysts at Bank of America from $133.00 to $150.00 in a report released on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the healthcare product maker’s stock. Bank of America‘s target price would indicate a potential upside of […] - 2025-03-12 06:08:55
- Congressmember Shelley Moore Capito's New Portfolio Holdings
- Quiver's Shelley Moore Capito Strategy is an automated trading strategy that tracks the performance of stocks that are being held by U.S. Congressmember Shelley Moore Capito (or their family).This strategy is rebalanced when new trades or annual reports are reported. The strategy - 2025-03-07 20:00:07
- Sen. Shelley Moore Capito Sells Abbott Laboratories (NYSE:ABT) Shares
- Senator Shelley Moore Capito (R-West Virginia) recently sold shares of Abbott Laboratories (NYSE:ABT). In a filing disclosed on March 06th, the Senator disclosed that they had sold between $1,001 and $15,000 in Abbott Laboratories stock on February 24th. Senator Shelley Moore Capito also recently made the following trade(s): Sold $1,001 – $15,000 in shares of […] - 2025-03-07 07:06:55
- Abbott Laboratories (NYSE:ABT) Reaches New 52-Week High Following Analyst Upgrade
- Abbott Laboratories (NYSE:ABT – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday after Citigroup raised their price target on the stock from $135.00 to $160.00. Citigroup currently has a buy rating on the stock. Abbott Laboratories traded as high as $141.23 and last traded at $137.65, with a volume […] - 2025-03-06 08:08:01
- Is Medtronic Stock Underperforming the Nasdaq?
- Medtronic has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects. - 2025-03-05 18:47:11
- Citigroup Issues Positive Forecast for Abbott Laboratories (NYSE:ABT) Stock Price
- Abbott Laboratories (NYSE:ABT – Free Report) had its price target lifted by Citigroup from $135.00 to $160.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a buy rating on the healthcare product maker’s stock. Several other analysts also recently weighed in on the stock. Barclays reissued an “overweight” rating and […] - 2025-03-05 10:06:53
- Intuitive Surgical Stock: Is ISRG Outperforming the Healthcare Sector?
- Intuitive Surgical's robust outperformance against the healthcare sector over the past year has reinforced Wall Street analysts' bullish outlook on the stock. - 2025-03-04 14:51:24
- Stock Traders Buy High Volume of Call Options on Abbott Laboratories (NYSE:ABT)
- Abbott Laboratories (NYSE:ABT – Get Free Report) was the target of some unusual options trading on Monday. Stock investors acquired 22,017 call options on the company. This is an increase of 73% compared to the average daily volume of 12,690 call options. Abbott Laboratories Stock Up 1.5 % Abbott Laboratories stock opened at $140.13 on […] - 2025-03-04 08:44:54
- XLV, ABT, TMO, PFE: Large Inflows Detected at ETF
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $849.0 million dollar inflow -- that's a 2.2% increase we - 2025-03-03 16:08:05
- Is Abbott Laboratories Stock Outperforming the Dow?
- Abbott Laboratories has notably outpaced the Dow Jones Industrial Average over the past year and analysts remain strongly bullish on the stock’s prospects. - 2025-03-03 14:36:49
- Abbott Laboratories Reaches Analyst Target Price
- In recent trading, shares of Abbott Laboratories (Symbol: ABT) have crossed above the average analyst 12-month target price of $136.09, changing hands for $138.01/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on - 2025-03-03 12:47:24
- Is Abbott Laboratories Stock Outperforming the Dow?
- Abbott Laboratories has notably outpaced the Dow Jones Industrial Average over the past year and analysts remain strongly bullish on the stock’s prospects. - 2025-03-03 10:45:41
- Insulet Stock Outlook: Is Wall Street Bullish or Bearish?
- Insulet has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects. - 2025-02-25 14:31:50
- 2,792 Shares in Abbott Laboratories (NYSE:ABT) Acquired by Strategic Financial Concepts LLC
- Strategic Financial Concepts LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 2,792 shares of the healthcare product maker’s stock, valued at approximately $316,000. Other institutional investors and hedge funds have also bought […] - 2025-02-21 09:41:02
- Congressmember Shelley Moore Capito's New Portfolio Holdings
- Quiver's Shelley Moore Capito Strategy is an automated trading strategy that tracks the performance of stocks that are being held by U.S. Congressmember Shelley Moore Capito (or their family).This strategy is rebalanced when new trades or annual reports are reported. The strategy - 2025-02-14 20:00:07
- Noteworthy ETF Inflows: SPXL, ABT, MCD, DIS
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P 500 Bull 3X (Symbol: SPXL) where we have detected an approximate $252.9 million dollar inflow -- that's a 5.1% increase week o - 2025-02-13 15:49:29
- Fund Update: Applied Finance Capital Management, LLC Just Disclosed New Holdings
- Applied Finance Capital Management, LLC just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other fun - 2025-02-13 15:04:32
- Strategic Financial Concepts LLC Purchases Shares of 272,961 Abbott Laboratories (NYSE:ABT)
- Strategic Financial Concepts LLC acquired a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the fourth quarter, HoldingsChannel reports. The firm acquired 272,961 shares of the healthcare product maker’s stock, valued at approximately $316,000. Several other institutional investors have also added to or reduced their stakes in ABT. Groupama Asset Managment […] - 2025-02-13 09:02:56
- Fund Update: B. Metzler seel. Sohn & Co. AG Just Disclosed New Holdings
- B. Metzler seel. Sohn & Co. AG just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-12 18:13:07
- Congress Trade: Representative Emily Randall Just Disclosed New Stock Trades
- Representative Emily Randall just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Emily Randall and other politicians. - 2025-02-12 14:37:37
- Abbott Laboratories (NYSE:ABT) Upgraded at StockNews.com
- StockNews.com upgraded shares of Abbott Laboratories (NYSE:ABT – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday. ABT has been the subject of a number of other research reports. UBS Group increased their price objective on shares of Abbott Laboratories from $146.00 to $148.00 and […] - 2025-02-07 08:37:16
- Abbott Laboratories Sees Unusually High Options Volume (NYSE:ABT)
- Abbott Laboratories (NYSE:ABT – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 26,157 call options on the stock. This represents an increase of 116% compared to the typical daily volume of 12,104 call options. Analyst Upgrades and Downgrades ABT has been the subject of several research reports. Stifel […] - 2025-02-07 06:47:04
- Noteworthy Wednesday Option Activity: WDAY, ABT, JNPR
- Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Workday Inc (Symbol: WDAY), where a total of 8,287 contracts have traded so far, representing approximately 828,700 underlying shares. That amounts to about 42.2% of WDAY - 2025-02-05 19:25:44
- iShares Core Conservative Allocation ETF Experiences Big Outflow
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core Conservative Allocation ETF (Symbol: AOK) where we have detected an approximate $69.7 million dollar outflow -- that's a 10.2% decrease - 2025-02-04 16:10:52
- After Hours Most Active for Jan 28, 2025 : NVDA, INTC, AAPL, ABT, SCHW, T, HPE, SBUX, MCHI, BSX, CSCO, TEVA
- The NASDAQ 100 After Hours Indicator is down -14.32 to 21,448.72. The total After hours volume is currently 109,434,312 shares traded.The following are the most active stocks for the after hours session: NVIDIA Corporation (NVDA) is -0.63 at $128.36, with 5,694,273 shares traded - 2025-01-28 21:24:59
- The Zacks Analyst Blog Highlights Cisco Systems, Abbott Laboratories and Coca-Cola
- Cisco Systems, Abbott Laboratories and Coca-Cola are part of the Zacks top Analyst Blog. - 2025-01-27 18:48:00
- Top Stock Reports for Cisco, Abbott & Coca-Cola
- Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems, Inc. (CSCO), Abbott Laboratories (ABT) and The Coca-Cola Company (KO). - 2025-01-24 21:21:00
- Congress Trade: Representative Thomas H. Kean, Jr. Just Disclosed New Stock Trades
- Representative Thomas H. Kean, Jr. just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Thomas H. Kean, Jr. and other politic - 2025-01-23 16:31:21
iShares Russell 2000 Swap UCITS ETF ABT holdings
| Date | Number of ABT Shares Held | Base Market Value of ABT Shares | Local Market Value of ABT Shares | Change in ABT Shares Held | Change in ABT Base Value | Current Price per ABT Share Held | Previous Price per ABT Share Held |
|---|
| 2025-02-26 (Wednesday) | -1,821 | USD -247,583 | USD -247,583 | 3,642 | USD 494,911 | USD 135.96 | USD 0 |
| 2025-02-26 (Wednesday) | 1,821 | USD 247,583 | USD 247,583 | 3,642 | USD 494,911 | USD 135.96 | USD 0 |
| 2025-02-25 (Tuesday) | -1,821 | USD -247,328 | USD -247,328 | 3,642 | USD 493,072 | USD 135.82 | USD 0 |
| 2025-02-25 (Tuesday) | 1,821 | USD 247,328 | USD 247,328 | 3,642 | USD 493,072 | USD 135.82 | USD 0 |
| 2025-02-24 (Monday) | -1,821 | USD -245,744 | USD -245,744 | 3,642 | USD 491,433 | USD 134.95 | USD 0 |
| 2025-02-24 (Monday) | 1,821 | USD 245,744 | USD 245,744 | 3,642 | USD 491,433 | USD 134.95 | USD 0 |
| 2025-02-21 (Friday) | -1,821 | USD -245,689 | USD -245,689 | 3,642 | USD 488,192 | USD 134.92 | USD 0 |
| 2025-02-21 (Friday) | 1,821 | USD 245,689 | USD 245,689 | 3,642 | USD 488,192 | USD 134.92 | USD 0 |
| 2025-02-20 (Thursday) | -1,821 | USD -242,503 | USD -242,503 | 3,642 | USD 483,112 | USD 133.17 | USD 0 |
| 2025-02-20 (Thursday) | 1,821 | USD 242,503 | USD 242,503 | 3,642 | USD 483,112 | USD 133.17 | USD 0 |
| 2025-02-19 (Wednesday) | -1,821 | USD -240,609 | USD -240,609 | 3,642 | USD 477,667 | USD 132.13 | USD 0 |
| 2025-02-19 (Wednesday) | 1,821 | USD 240,609 | USD 240,609 | 3,642 | USD 477,667 | USD 132.13 | USD 0 |
| 2025-02-18 (Tuesday) | -1,821 | USD -237,058 | USD -237,058 | 3,642 | USD 474,899 | USD 130.18 | USD 0 |
| 2025-02-18 (Tuesday) | 1,821 | USD 237,058 | USD 237,058 | 3,642 | USD 474,899 | USD 130.18 | USD 0 |
| 2025-02-14 (Friday) | -1,821 | USD -237,841 | USD -237,841 | 3,642 | USD 477,831 | USD 130.61 | USD 0 |
| 2025-02-14 (Friday) | 1,821 | USD 237,841 | USD 237,841 | 3,642 | USD 477,831 | USD 130.61 | USD 0 |
| 2025-02-13 (Thursday) | -1,821 | USD -239,990 | USD -239,990 | 3,642 | USD 477,612 | USD 131.79 | USD 0 |
| 2025-02-13 (Thursday) | 1,821 | USD 239,990 | USD 239,990 | 3,642 | USD 477,612 | USD 131.79 | USD 0 |
| 2025-02-12 (Wednesday) | -1,821 | USD -237,622 | USD -237,622 | 3,642 | USD 476,974 | USD 130.49 | USD 0 |
| 2025-02-12 (Wednesday) | 1,821 | USD 237,622 | USD 237,622 | 3,642 | USD 476,974 | USD 130.49 | USD 0 |
| 2025-02-11 (Tuesday) | -1,821 | USD -239,352 | USD -239,352 | 3,642 | USD 478,468 | USD 131.44 | USD 0 |
| 2025-02-11 (Tuesday) | 1,821 | USD 239,352 | USD 239,352 | 3,642 | USD 478,468 | USD 131.44 | USD 0 |
| 2025-02-10 (Monday) | -1,821 | USD -239,116 | USD -239,116 | 3,642 | USD 474,152 | USD 131.31 | USD 0 |
| 2025-02-10 (Monday) | 1,821 | USD 239,116 | USD 239,116 | 3,642 | USD 474,152 | USD 131.31 | USD 0 |
| 2025-02-07 (Friday) | -1,821 | USD -235,036 | USD -235,036 | 3,642 | USD 468,525 | USD 129.07 | USD 0 |
| 2025-02-07 (Friday) | 1,821 | USD 235,036 | USD 235,036 | 3,642 | USD 468,525 | USD 129.07 | USD 0 |
| 2025-02-06 (Thursday) | 1,821 | USD 233,489 | USD 233,489 | 3,642 | USD 473,970 | USD 128.22 | USD 0 |
| 2025-02-06 (Thursday) | -1,821 | USD -233,489 | USD -233,489 | 3,642 | USD 473,970 | USD 128.22 | USD 0 |
| 2025-02-05 (Wednesday) | -1,821 | USD -240,481 | USD -240,481 | 3,642 | USD 475,572 | USD 132.06 | USD 0 |
| 2025-02-05 (Wednesday) | 1,821 | USD 240,481 | USD 240,481 | 3,642 | USD 475,572 | USD 132.06 | USD 0 |
| 2025-02-04 (Tuesday) | -1,821 | USD -235,091 | USD -235,091 | 3,642 | USD 468,998 | USD 129.1 | USD 0 |
| 2025-02-04 (Tuesday) | 1,821 | USD 235,091 | USD 235,091 | 3,642 | USD 468,998 | USD 129.1 | USD 0 |
| 2025-02-03 (Monday) | -1,821 | USD -233,907 | USD -233,907 | 3,642 | USD 466,868 | USD 128.45 | USD 0 |
| 2025-02-03 (Monday) | 1,821 | USD 233,907 | USD 233,907 | 3,642 | USD 466,868 | USD 128.45 | USD 0 |
| 2025-01-31 (Friday) | -1,821 | USD -232,961 | USD -232,961 | 3,642 | USD 467,524 | USD 127.93 | USD 0 |
| 2025-01-31 (Friday) | 1,821 | USD 232,961 | USD 232,961 | 3,642 | USD 467,524 | USD 127.93 | USD 0 |
| 2025-01-30 (Thursday) | 1,821 | USD 234,563 | USD 234,563 | -3,642 | USD -469,126 | USD 109.57 | USD 0 |
| 2025-01-30 (Thursday) | -1,821 | USD -234,563 | USD -234,563 | -3,642 | USD -469,126 | USD 109.57 | USD 0 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of ABT by Blackrock for IE0007O06KL9
Show aggregate share trades of ABT| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-02-26 | BUY | 3,642 | | | 135.960* | | 130.07 |
| 2025-02-25 | BUY | 3,642 | | | 135.820* | | 129.73 |
| 2025-02-24 | BUY | 3,642 | | | 134.950* | | 129.40 |
| 2025-02-21 | BUY | 3,642 | | | 134.920* | | 129.03 |
| 2025-02-20 | BUY | 3,642 | | | 133.170* | | 128.74 |
| 2025-02-19 | BUY | 3,642 | | | 132.130* | | 128.48 |
| 2025-02-18 | BUY | 3,642 | | | 130.180* | | 128.34 |
| 2025-02-14 | BUY | 3,642 | | | 130.610* | | 128.13 |
| 2025-02-13 | BUY | 3,642 | | | 131.790* | | 127.76 |
| 2025-02-12 | BUY | 3,642 | | | 130.490* | | 127.46 |
| 2025-02-11 | BUY | 3,642 | | | 131.440* | | 126.96 |
| 2025-02-10 | BUY | 3,642 | | | 131.310* | | 126.34 |
| 2025-02-07 | BUY | 3,642 | | | 129.070* | | 125.89 |
| 2025-02-06 | BUY | 3,642 | | | 128.220* | | 125.42 |
| 2025-02-05 | BUY | 3,642 | | | 132.060* | | 123.76 |
| 2025-02-04 | BUY | 3,642 | | | 129.100* | | 121.98 |
| 2025-02-03 | BUY | 3,642 | | | 128.450* | | 118.75 |
| 2025-01-31 | BUY | 3,642 | | | 127.930* | | 109.57 |
| 2025-01-30 | SELL | -3,642 | | | 109.570* | | 0.00 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of ABT
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-03-12 | 990,160 | 791 | 2,592,982 | 38.2% |
| 2025-03-11 | 1,432,038 | 404 | 2,978,311 | 48.1% |
| 2025-03-10 | 1,101,363 | 2,026 | 3,107,376 | 35.4% |
| 2025-03-07 | 1,088,348 | 1,452 | 3,118,337 | 34.9% |
| 2025-03-06 | 1,157,026 | 2,684 | 4,213,037 | 27.5% |
| 2025-03-05 | 1,441,883 | 1,043 | 2,931,110 | 49.2% |
| 2025-03-04 | 867,337 | 1,277 | 3,359,982 | 25.8% |
| 2025-03-03 | 1,637,230 | 1,727 | 3,036,529 | 53.9% |
| 2025-02-28 | 1,201,980 | 1,728 | 2,880,836 | 41.7% |
| 2025-02-27 | 926,280 | 853 | 2,252,111 | 41.1% |
| 2025-02-26 | 1,175,276 | 3,751 | 2,083,943 | 56.4% |
| 2025-02-25 | 1,118,029 | 3,413 | 2,227,390 | 50.2% |
| 2025-02-24 | 968,290 | 7,313 | 2,545,175 | 38.0% |
| 2025-02-21 | 1,244,572 | 1,522 | 2,213,728 | 56.2% |
| 2025-02-20 | 834,228 | 145 | 1,510,152 | 55.2% |
| 2025-02-19 | 754,044 | 1,370 | 1,488,518 | 50.7% |
| 2025-02-18 | 1,026,159 | 1,895 | 1,533,372 | 66.9% |
| 2025-02-14 | 762,803 | 31 | 1,165,798 | 65.4% |
| 2025-02-13 | 860,070 | 650 | 1,453,123 | 59.2% |
| 2025-02-12 | 1,122,505 | 679 | 1,864,535 | 60.2% |
| 2025-02-11 | 1,279,366 | 67 | 2,125,122 | 60.2% |
| 2025-02-10 | 1,444,288 | 11,406 | 2,057,453 | 70.2% |
| 2025-02-07 | 1,114,162 | 40,854 | 1,729,736 | 64.4% |
| 2025-02-06 | 1,133,532 | 3,405 | 2,499,921 | 45.3% |
| 2025-02-05 | 1,873,138 | 4,655 | 3,280,183 | 57.1% |
| 2025-02-04 | 1,220,681 | 274 | 3,225,370 | 37.8% |
| 2025-02-03 | 971,641 | 1,145 | 1,844,896 | 52.7% |
| 2025-01-31 | 952,255 | 681 | 2,229,333 | 42.7% |
| 2025-01-30 | 1,099,325 | 124 | 2,472,289 | 44.5% |
| 2025-01-29 | 1,382,243 | 1,244 | 2,700,181 | 51.2% |
| 2025-01-28 | 2,059,314 | 2,643 | 4,267,892 | 48.3% |
| 2025-01-27 | 1,909,129 | 3,294 | 4,289,694 | 44.5% |
| 2025-01-24 | 2,054,086 | 5,270 | 4,285,670 | 47.9% |
| 2025-01-23 | 2,404,163 | 3,002 | 5,012,391 | 48.0% |
| 2025-01-22 | 2,619,580 | 855 | 4,946,793 | 53.0% |
| 2025-01-21 | 1,620,136 | 852 | 3,304,934 | 49.0% |
| 2025-01-17 | 945,677 | 517 | 1,671,106 | 56.6% |
| 2025-01-16 | 835,096 | 1,367 | 1,912,137 | 43.7% |
| 2025-01-15 | 896,108 | 4,678 | 2,319,310 | 38.6% |
| 2025-01-14 | 888,808 | 3,830 | 1,451,056 | 61.3% |
| 2025-01-13 | 941,232 | 1,010 | 1,452,049 | 64.8% |
| 2025-01-10 | 1,137,422 | 2,677 | 1,826,919 | 62.3% |
| 2025-01-08 | 852,349 | 1,759 | 1,359,885 | 62.7% |
| 2025-01-07 | 655,928 | 197 | 1,425,666 | 46.0% |
| 2025-01-06 | 637,434 | 6,556 | 1,484,890 | 42.9% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.